All COVID-19 – Page 28 – BIDMC’s COVID-19 Initiatives

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) shared how the COVID-19 experience will almost certainly change the future of vaccine science.

The lightning-fast quest for COVID vaccines — and what it means for other diseases

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) spoke to whether taking more than one type of COVID-19 vaccine is better for boosting immunity against the virus.

Should people take more than one type of COVID-19 vaccine?

The New York Times detailed how the Johnson & Johnson and BIDMC COVD-19 vaccine candidate works. The vaccine is being developed in collaboration between Johnson & Johnson and BIDMC, led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC).

How the Johnson & Johnson Vaccine Works

As millions of the Pfizer and Moderna COVID-19 vaccines are expected to be distributed before year’s end, Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) says these two vaccines alone are not enough for rapid distribution in the U.S. and certainly not globally.

More vaccines need authorization to inoculate all Americans

This front page story and companion video follow the arrival of the Pfizer/BioNTech vaccine to BIDMC, featuring the perspectives of BILH and BIDMC leaders as well as patient-facing staff who received the vaccine.

Vaccinations boost spirits at hospitals throughout Ma...

According to federal officials, at least 40 million doses of the Pfizer and Moderna vaccines should be available by the end of the year and many more are expected next year. A third vaccine, developed in collaboration between Johnson & Johnson and BIDMC, led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) is in a late-stage clinical trial, with results expected early 2021.

What you need to know about Moderna’s COVID-19 vaccine, which is likely to get cleared this week

Researchers led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) studied levels of antibodies and immune cells required to prevent reinfection of the COVID-19 virus in rhesus macaques.

Antibodies and T cells protect against SARS-CoV-2

Hospitals across the U.S. are expecting to receive the first shipments of Pfizer’s COVID-19 vaccine as soon as Monday. Daniel Talmor, MD, MPH (Anesthesiology, Critical Care, BIDMC) shared how the vaccine is the light at the end of the tunnel.

"Without A Vaccine, We Don't Get Out Of This," BIDMC Doctor Says

The earliest shipments of COVID-19 vaccine are expected to arrive at some Massachusetts hospitals starting Monday. Sharon Wright, MD, MPH (Infectious Disease, BILH) discussed how focusing the vaccination process on health workers may help broaden support for the vaccine among the public.

With vaccine to arrive, Mass. goes from ‘defense to offense’ against COVID-19

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50